Compare iShares JPMorgan USD Emerging Markets Bond ETF (EMB) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares JPMorgan USD Emerging Markets Bond ETF vs GeneDx Holdings Corp — how do they compare? iShares JPMorgan USD Emerging Markets Bond ETF trades at $94.83, while GeneDx Holdings Corp trades at $82.71 (market cap $2.44B). Which is the better fit depends on your goals.
| EMB | WGS | |
|---|---|---|
Sector | Fixed Income | Technology |
52-Week High | $97.74 | $167.51 |
52-Week Low | $92.95 | $34.51 |
Market Cap | — | $2.44B |
Enterprise Value | — | $2.48B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EMB trades at $94.94, up 0.11% today, but technical indicators signal a bearish trend with moving averages and overall signals favoring sell positions. The stock lacks disclosed valuation and profitability ratios, limiting fundamental clarity. Recent corporate actions include scheduled dividends in mid-2026, but no current income statement or cash flow data is available to assess recent performance.
The outlook is cautious due to bearish technicals and incomplete financial disclosures. Risks include reliance on future dividend payments without current earnings visibility. Investors should await updated financials for a clearer fundamental picture amid weak technical momentum.
GeneDx Holdings Corp (WGS) trades at $82.39, up 5.79% in the past 24 hours, with a bullish technical signal and strong analyst support. The company reported Q2 2026 revenue of $114.4 million, beating guidance, and returned to adjusted profitability earlier than expected. However, net income remains negative at -$106 million for 2026, and the stock faces class action lawsuits with an August 3, 2026 deadline.
Outlook is mixed: bullish technicals and analyst consensus suggest upside to the $90 price target, but fundamental weaknesses and legal risks pose significant challenges. Investment opportunity hinges on sustained revenue growth and margin improvement, while risks include profitability pressures and litigation outcomes.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About iShares JPMorgan USD Emerging Markets Bond ETF
EMB invests in U.S. dollar-denominated sovereign debt from emerging market countries. It provides exposure to government bonds from dozens of nations like Turkey, Mexico, and Brazil, offering a way to seek higher yields and geographic diversification.
Read more on EMB →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
